Targeting smokers coming and going
This article was originally published in The Tan Sheet
Executive SummaryReynolds American, the No. 2 U.S. tobacco firm, might enter the smoking-cessation market by acquiring Niconovum, a Swedish firm that manufactures Zonnic nicotine-replacement therapy gum and mouth sprays. Media reported buying Niconovum would align with Reynolds' interest in marketing nicotine products less harmful than cigarettes. The Winston-Salem, N.C.-based company currently is testing dissolvable tobacco tablets in the U.S. after introducing Swedish-style Camel snus earlier this year. Other tobacco firms also likely want to enter the NRT market through acquisitions since Congress instructed FDA to further smoking-cessation efforts in the recently enacted law giving the agency authority over tobacco
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.